Skip to main content
. 2024 Nov 18;6(1):vdae189. doi: 10.1093/noajnl/vdae189

Figure 2.

Figure 2.

Progression-free survival of grade 3 gliomas, IDH-mutant (n = 106) in the whole series (A), by adjuvant oncological treatment (B), by extent of resection (C), and by histo-molecular subtype (D).